1. SARS-CoV-2 viremia but not respiratory viral load is associated with respiratory complications in patients with severe COVID-19
- Author
-
Lingye Chen, Lyra B. Olson, Ibtehaj A. Naqvi, Bruce A. Sullenger, Loretta G. Que, Thomas N. Denny, and Bryan D. Kraft
- Subjects
COVID-19 ,COVID-19 nucleic acid testing ,Pneumonia ,Ventilator-associated pneumonia ,Respiration, artificial ,Biomarkers/blood ,Diseases of the respiratory system ,RC705-779 - Abstract
Abstract Background Severe COVID-19 carries a high morbidity and mortality. Previous studies have shown an association between COVID-19 severity and SARS-CoV-2 viral load (VL). We sought to measure VL in multiple compartments (urine, plasma, lower respiratory tract) in patients admitted to the intensive care unit (ICU) with severe COVID-19 pneumonia and correlate with clinical outcomes. Methods Plasma, urine, and endotracheal aspirate (ETA) samples were obtained on days 1, 3, 7, 14, and 21 from subjects admitted to the ICU with severe COVID-19. VL was measured via reverse transcriptase polymerase chain reaction. Clinical data was collected from the electronic health record. Grouped comparisons were performed using Student’s t-test or 1-way ANOVA. Linear regression was used to correlate VL from different compartments collected at the same time. Logistic regression was performed to model ventilator-freedom at 28 days as a function of peak plasma VL. Results We enrolled 57 subjects with severe COVID-19 and measured VL in plasma (n = 57), urine (n = 25), and ETA (n = 34). Ventilator-associated pneumonia developed in 63% of subjects. 49% of subjects were viremic on study day 1. VL in plasma and ETA both significantly decreased by day 14 (P
- Published
- 2024
- Full Text
- View/download PDF